Join to View Full Profile
1400 Pin Oak DrCarterville, IL 62918
Phone+1 618-985-3333
Fax+1 618-985-1318
Dr. Shafqat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Hammad Shafqat is an oncologist in Carterville, IL. He has been in practice 7 years. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.
Education & Training
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 2012 - 2014
Army Medical College Quaid-e-Azam UnivClass of 2010
Medical University of South CarolinaFellowship, Hematology and Medical Oncology
Certifications & Licensure
IL State Medical License 2017 - 2026
KY State Medical License 2023 - 2026
SC State Medical License 2015 - 2018
RI State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 53 citationsImmune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy.Hammad Shafqat, Theodore Stewart Gourdin, Amy Sion
Seminars in Oncology. 2018-06-01 - 28 citationsAdjuvant Therapy for Resected Gallbladder Cancer: Analysis of the National Cancer Data Base.Kalyan Mantripragada, Fatima Hamid, Hammad Shafqat, Adam J. Olszewski
Journal of the National Cancer Institute. 2017-02-01 - 9 citationsHypertriglyceridemia-Induced Pancreatitis: A Decade of Experience in a Community-Based Teaching Hospital.Maxwell Afari, Hammad Shafqat, Muhammad Ismail Shafi, Fady Y. Marmoush, Mary B. Roberts
Rhode Island Medical Journal. 2015-12-01
Press Mentions
Baseline Steroids May Impact Immunotherapy Efficacy in Lung CancerSeptember 27th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
